1. Home
  2. AMRX vs NHI Comparison

AMRX vs NHI Comparison

Compare AMRX & NHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$11.98

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Logo National Health Investors Inc.

NHI

National Health Investors Inc.

HOLD

Current Price

$78.32

Market Cap

3.7B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMRX
NHI
Founded
2002
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.7B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
AMRX
NHI
Price
$11.98
$78.32
Analyst Decision
Buy
Buy
Analyst Count
4
5
Target Price
$13.25
$84.80
AVG Volume (30 Days)
1.7M
168.9K
Earning Date
10-30-2025
11-06-2025
Dividend Yield
N/A
4.70%
EPS Growth
N/A
8.88
EPS
0.02
3.17
Revenue
$2,934,959,000.00
$357,572,000.00
Revenue This Year
$9.99
$5.50
Revenue Next Year
$6.67
$11.38
P/E Ratio
$745.76
$24.73
Revenue Growth
9.50
8.40
52 Week Low
$6.69
$65.13
52 Week High
$12.68
$80.56

Technical Indicators

Market Signals
Indicator
AMRX
NHI
Relative Strength Index (RSI) 55.77 54.19
Support Level $11.83 $77.74
Resistance Level $12.25 $79.82
Average True Range (ATR) 0.33 1.30
MACD -0.08 -0.08
Stochastic Oscillator 44.31 29.51

Price Performance

Historical Comparison
AMRX
NHI

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About NHI National Health Investors Inc.

National Health Investors Inc is a housing and medical facility REIT. The company operates through two reportable segments, i.e., Real Estate Investments and Senior Housing Operating Portfolio (SHOP). The Real Estate Investments segment, which generates maximum revenue, consists of real estate investments and leases, mortgages, and other notes receivables in independent living facilities, assisted living facilities, entrance fee communities, senior living campuses, skilled nursing facilities, and a hospital. The SHOP segment is comprised of two ventures that own the operations of independent living facilities. The company's revenues are derived in the form of rental income, mortgage and other notes receivable interest income, and resident fees and services.

Share on Social Networks: